| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 12.717 | 37.304 | 53.817 | 57.470 | 58.085 | 71.496 |
| Total Income - EUR | - | - | - | - | 12.717 | 37.346 | 53.821 | 57.470 | 58.087 | 71.503 |
| Total Expenses - EUR | - | - | - | - | 9.253 | 33.430 | 47.363 | 47.012 | 47.042 | 48.236 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.464 | 3.916 | 6.458 | 10.457 | 11.045 | 23.268 |
| Net Profit/Loss - EUR | - | - | - | - | 3.336 | 3.550 | 5.919 | 9.902 | 10.464 | 21.123 |
| Employees | - | - | - | - | 1 | 3 | 3 | 3 | 2 | 3 |
Check the financial reports for the company - Genasmefa Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 93 | 69 | 47 | 26 | 1.058 | 2.330 |
| Current Assets | - | - | - | - | 4.254 | 8.275 | 15.560 | 17.881 | 19.590 | 20.669 |
| Inventories | - | - | - | - | 246 | 173 | 79 | 0 | 1.280 | 230 |
| Receivables | - | - | - | - | 3.642 | 3.542 | 6.918 | 2.566 | 11.385 | 7.131 |
| Cash | - | - | - | - | 367 | 4.560 | 8.563 | 15.315 | 6.925 | 13.308 |
| Shareholders Funds | - | - | - | - | 3.379 | 6.865 | 12.632 | 16.170 | 17.870 | 21.171 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 968 | 1.479 | 2.975 | 1.737 | 2.777 | 1.828 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Genasmefa Med S.r.l.